FLNA:BMV
Filana Therapeutics Inc
15,92 MX$
0,00%
(0,00) 1D
5. okt., 12.05.31 GMT-6 · MXN
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for FLNA...
Markedsværdi
39,63 mio.
Gns. vol.
0,00
Volumen
1,00
Højeste i 52 uger
56,00 MX$
Laveste i 52 uger
15,92 MX$
Antal ansatte
19
Markedsværdi
39,63 mio.
Gns. vol.
0,00
Volumen
1,00
Højeste i 52 uger
56,00 MX$
Laveste i 52 uger
15,92 MX$
Antal ansatte
19
Nyhedshistorier
Fra webkilder og nyhedspartnere
Traders Union
·
for 3 timer siden
S&P 500's stigninger siden 2019 er drevet af indtjening og udbytter, bemærker Ryan Detrick
Stock Titan
·
for 29 minutter siden
A humanoid robot for developers and schools is among four launches planned for Oct. 14.
Foreign Policy Journal
·
for 54 minutter siden
Lululemon (NASDAQ: LULU) Faces Brand Reckoning As Sales Slump And Hedge Funds Retreat
Barchart.com
·
for 3 timer siden
The S&P 500 Is Near Record Highs. So Why Does Your Portfolio Feel Like a Bear Market?
Profil
Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. Currently led by President and CEO Richard Barry, Filana is working on developing simufilam to treat tuberous sclerosis complex–related epilepsy. The company previously was developing simufilam as an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials.
In June 2024, the United States Department of Justice charged an advisor to Cassava Hoau-Yan Wang, with fraud over research results related to the experimental drug. Less than a month later, the president, chief executive officer and chairman of the board, Remi Barbier, resigned along with Lindsay Burns, his wife, who was the company's senior vice president and Wang's co-author. The U.S. Securities and Exchange Commission filed fraud charges in September 2024 against Barbier, Burns and Wang. The parties did not admit wrongdoing, but agreed to pay fines of the company $40 million, Barbier $175,000, Burns $85,000, and Wang $50,000. Wikipedia
Om Filana Therapeutics Inc
Administrerende direktør-
Ansatte19
Grundlagt1998
HovedsædeAustin, Texas, USA
Sektor-
Websitepaintrials.com